BEAM
Price
$27.87
Change
+$0.87 (+3.22%)
Updated
Oct 9 closing price
Capitalization
2.83B
28 days until earnings call
Intraday BUY SELL Signals
FTRE
Price
$10.75
Change
+$0.62 (+6.12%)
Updated
Oct 9 closing price
Capitalization
1.56B
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs FTRE

Header iconBEAM vs FTRE Comparison
Open Charts BEAM vs FTREBanner chart's image
Beam Therapeutics
Price$27.87
Change+$0.87 (+3.22%)
Volume$2.63M
Capitalization2.83B
Fortrea Holdings
Price$10.75
Change+$0.62 (+6.12%)
Volume$1.56M
Capitalization1.56B
BEAM vs FTRE Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. FTRE commentary
Feb 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and FTRE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 03, 2026
Stock price -- (BEAM: $27.92 vs. FTRE: $16.86)
Brand notoriety: BEAM and FTRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. FTRE: 106%
Market capitalization -- BEAM: $2.83B vs. FTRE: $1.56B
BEAM [@Biotechnology] is valued at $2.83B. FTRE’s [@Biotechnology] market capitalization is $1.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileFTRE’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • FTRE’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and FTRE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while FTRE’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • FTRE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, FTRE is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -9.79% price change this week, while FTRE (@Biotechnology) price change was -1.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +50.74%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +33.78%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

FTRE is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+50.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.83B) has a higher market cap than FTRE($1.56B). BEAM YTD gains are higher at: 0.722 vs. FTRE (-2.261). BEAM has higher annual earnings (EBITDA): -434.55M vs. FTRE (-852.7M). BEAM has more cash in the bank: 1.08B vs. FTRE (131M). BEAM has less debt than FTRE: BEAM (151M) vs FTRE (1.19B). FTRE has higher revenues than BEAM: FTRE (2.76B) vs BEAM (55.7M).
BEAMFTREBEAM / FTRE
Capitalization2.83B1.56B182%
EBITDA-434.55M-852.7M51%
Gain YTD0.722-2.261-32%
P/E RatioN/AN/A-
Revenue55.7M2.76B2%
Total Cash1.08B131M821%
Total Debt151M1.19B13%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMFTRE
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
76%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 20 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
FTRE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCRFX14.010.09
+0.65%
BlackRock Mid-Cap Value Investor C
PASRX21.380.11
+0.52%
Putnam Dynamic Asset Allocation Gr R
MGRQX43.400.15
+0.35%
MFS International Growth R2
ARFFX18.72N/A
N/A
Ariel Focus Investor
MATFX18.23-0.14
-0.76%
Matthews Asia Innovators Investor

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+1.09%
CRSP - BEAM
72%
Closely correlated
+2.70%
RXRX - BEAM
62%
Loosely correlated
-0.24%
NTLA - BEAM
62%
Loosely correlated
-0.68%
PRME - BEAM
61%
Loosely correlated
-0.26%
VIR - BEAM
58%
Loosely correlated
+3.63%
More

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+0.30%
BEAM - FTRE
45%
Loosely correlated
+1.09%
SYRE - FTRE
45%
Loosely correlated
+2.41%
TECH - FTRE
42%
Loosely correlated
+1.81%
ALGS - FTRE
41%
Loosely correlated
-1.49%
NTLA - FTRE
41%
Loosely correlated
-0.68%
More